Evidence map›Paper›PMID 25426854›Full record

ArticlePloS one2014

Synonymous rare arginine codons and tRNA abundance affect protein production and quality of TEV protease variant.

Jie Fang, Lingling Zou, Xuan Zhou, Beijiu Cheng, Jun Fan

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jie FangKey Laboratory of Crop Biology of Anhui Province, School of Life Science, Anhui Agricultural University, Hefei, Anhui, PR China.
Lingling ZouKey Laboratory of Crop Biology of Anhui Province, School of Life Science, Anhui Agricultural University, Hefei, Anhui, PR China.
Xuan ZhouKey Laboratory of Crop Biology of Anhui Province, School of Life Science, Anhui Agricultural University, Hefei, Anhui, PR China.
Beijiu ChengKey Laboratory of Crop Biology of Anhui Province, School of Life Science, Anhui Agricultural University, Hefei, Anhui, PR China.
Jun FanKey Laboratory of Crop Biology of Anhui Province, School of Life Science, Anhui Agricultural University, Hefei, Anhui, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been identified that a TEV protease (TEVp) variant, TEVp(5M), displays improved solubility. Here, we constructed fifteen TEVp(5M) variants with one or more of six rare arginine codons in the coding sequence replaced with abundant E. coli arginine codons. These codon variants expressed in either E. coli BL21 (DE3) or Rossetta (DE3) showed different solubility and activity. Supply of rare tRNAs increased the tendency of certain codon variants to form insoluble aggregates at early induction stage, as determined by the fused S-tag. About 32% increase in soluble protein production of M5 variant with four synonymously mutated arginine codons was identified in Rossetta (DE3) cells using GFP fusion reporter, comparable to that of TEVp(5M). After purification, two other codon variants from both E. coli strains exhibited less activity than TEVp(5M) on cleaving the native or modified recognition sequence incorporated between GST and E. coli diaminopropionate ammonialyase by enzyme-coupled assay, whereas purified M5 variant showed activity similar to the TEVp(5M). Supply of rare tRNAs caused the decrease of activity of TEVp(5M) and M5 by about 21%. Our results revealed that engineering of highly soluble TEVp variants can be achieved by the combined mutations of amino acid residues and optimization of specific rare codons, whereas simple augment of rare tRNAs abundance resulted in partial loss of activity.

Indexed as

Gene Expression Regulation, BacterialArginineCodonEndopeptidasesEscherichia coliGenetic EngineeringIsoenzymesMutagenesis, Site-DirectedMutationOpen Reading FramesPlasmidsProtein BiosynthesisRecombinant ProteinsRNA, TransferSolubilityArginineCodonEndopeptidasesIsoenzymesRecombinant ProteinsRNA, TransferTEV protease

Identifiers

PMID25426854
PMCPMC4245098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.